0.95
price up icon5.04%   0.0456
pre-market  プレマーケット:  .95  
loading

Renovorx Inc (RNXT) 最新ニュース

pulisher
01:57 AM

Is RenovoRx Inc. stock near bottom after declineJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - Newser

01:57 AM
pulisher
Dec 03, 2025

What makes RenovoRx Inc. stock attractive to growth funds2025 Momentum Check & Weekly Chart Analysis and Guides - Newser

Dec 03, 2025
pulisher
Dec 01, 2025

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th - Investing News Network

Dec 01, 2025
pulisher
Dec 01, 2025

RenovoRx CEO to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 - Quiver Quantitative

Dec 01, 2025
pulisher
Dec 01, 2025

RenovoRx (Nasdaq: RNXT) CEO to detail RenovoCath updates at iAccess Alpha - Stock Titan

Dec 01, 2025
pulisher
Nov 26, 2025

RenovoRx files $50M mixed securities shelf - MSN

Nov 26, 2025
pulisher
Nov 26, 2025

Big Money Moves: Is RenovoRx Inc. stock attractive for growth ETFsMarket Trend Review & Safe Entry Zone Tips - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 24, 2025

RenovoRx CMO Makes Bold Stock Purchase - TipRanks

Nov 24, 2025
pulisher
Nov 24, 2025

[Form 4] RenovoRx, Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

RenovoRx CMO Ramtin Agah Acquires 22,000 Shares - TradingView

Nov 24, 2025
pulisher
Nov 23, 2025

Cipla Limited (CIPLA) Gets Regulatory ApprovalFinancial Sector Performance & Stay One Step Ahead of Risk Events - earlytimes.in

Nov 23, 2025
pulisher
Nov 21, 2025

Is RenovoRx Inc. stock positioned for long term growthRisk Management & Reliable Volume Spike Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is RenovoRx Inc. stock a top pick in earnings seasonWeekly Profit Report & Community Driven Trade Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

RenovoRx Expands Reach with RenovoCath Approval - MSN

Nov 20, 2025
pulisher
Nov 19, 2025

Is RenovoRx Inc. stock dividend yield sustainablePortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 17:29:20 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tick level data insight on RenovoRx Inc. volatility2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to integrate RenovoRx Inc. into portfolio analysis toolsQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th - Investing News Network

Nov 19, 2025
pulisher
Nov 19, 2025

RenovoRx CEO Shaun Bagai to Present at Alliance Global Partners Virtual Showcase on Oncology Innovations - Quiver Quantitative

Nov 19, 2025
pulisher
Nov 19, 2025

RenovoRx (Nasdaq: RNXT) to Share RenovoCath, $900K YTD Revenue at AGP Showcase - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

What drives RenovoRx Inc stock pricePrice Gap Trading Strategies & Go Beyond the Headlines With Analyst Picks - earlytimes.in

Nov 19, 2025
pulisher
Nov 19, 2025

Does RenovoRx Inc. fit your quant trading modelJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

RenovoRx : Corporate Overview - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

Strategic Expansion and Promising Clinical Results Justify Buy Rating for RenovoRx - TipRanks

Nov 18, 2025
pulisher
Nov 17, 2025

Can RenovoRx Inc. stock deliver consistent earnings growthJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com

Nov 17, 2025
pulisher
Nov 15, 2025

RenovoRx launches public stock offering - MSN

Nov 15, 2025
pulisher
Nov 15, 2025

Is RenovoRx Inc. stock supported by innovation pipelineBull Run & Free Safe Entry Trade Signal Reports - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Can machine learning forecast RenovoRx Inc. recoveryJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

RenovoRx Earnings Call: Positive Momentum and Strategic Growth - MSN

Nov 15, 2025
pulisher
Nov 15, 2025

RenovoRx’s Innovative Cancer Treatment and Promising Phase 3 Study Drive Buy Rating - TipRanks

Nov 15, 2025
pulisher
Nov 15, 2025

RenovoRx price target lowered to $3 from $3.50 at Alliance Global - MSN

Nov 15, 2025
pulisher
Nov 15, 2025

What analyst consensus says on RenovoRx Inc. stockWeekly Investment Recap & Smart Swing Trading Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

RenovoRx Enters Capital on Demand Sales Agreement - TipRanks

Nov 14, 2025
pulisher
Nov 14, 2025

[8-K] RenovoRx, Inc. Reports Material Event | RNXT SEC FilingForm 8-K - Stock Titan

Nov 14, 2025
pulisher
Nov 14, 2025

RenovoRx may offer securities for up to $50 millionSEC filing - MarketScreener

Nov 14, 2025
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
大文字化:     |  ボリューム (24 時間):